---
title: PLANet 2'0  AHCC12 and AHCC13
permalink: /ahcc-trials-group/current-trials/planet-2-ahcc12-and-ahcc13/
description: ""
third_nav_title: Current Trials
variant: tiptap
---
<table style="minWidth: 50px">
<colgroup>
<col>
<col>
</colgroup>
<tbody>
<tr>
<th rowspan="1" colspan="1">
<p><strong>AHCC12 &amp; AHCC13</strong>
</p>
</th>
<th rowspan="1" colspan="1">
<p>Precision Medicine in Liver Cancer across an Asia Pacific Network 2.0
(PLANet 2.0) (NCT05516628)</p>
<p><strong>AHCC12:</strong>
</p>
<p>Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence
to Adjuvant Atezolizumab plus Bevacizumab in Resected Hepatocellular Carcinoma
(HCC)(EMPHASIS)(NCT05516628)</p>
<p><strong>AHCC13:</strong>
</p>
<p>Liquid Biopsy based Identification of Predictive Biomarkers of Response
in Intermediate/Locally Advanced HCC receiving Y90 +/- Atezolizumab plus
Bevacizumab (NCT05377034)</p>
</th>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Status</p>
</td>
<td rowspan="1" colspan="1">
<p>Recruiting</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Contributing Principal Investigators and Centres</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Singapore</strong>
</p>
<p>Adrian Chiow (Changi General Hospital), Toh Han Chong (National Cancer
Centre), Chee Cheng Ean (National University Hospital), Kam Juinn Huar
(Sengkang General Hospital), Brian Goh (Singapore General Hospital), Samol
Jens (Tan Tock Seng Hospital)</p>
<p><strong>Up to 11 overseas sites in Asia-Pacific</strong>
</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Thematic Principal Investigators</p>
</td>
<td rowspan="1" colspan="1">
<p><strong>Theme 1: Deep Phenotyping and Correlation with Clinical Responses to Therapy</strong>
</p>
<p>Name: Pierce Chow
<br>Designation: Senior Consultant
<br>Institution: National Cancer Centre</p>
<p>Name: Patrick Tan
<br>Designation: Executive Director
<br>Institution: A*STAR Genome Institute of Singapore</p>
<p><strong>Theme 2: Elucidating Spatial Distribution of Biomarkers at Single-cell Resolution</strong>
</p>
<p>Name: Vinay Tergaonkar
<br>Designation: Research Director
<br>Institution: A*STAR Institute of Molecular and Cell Biology</p>
<p><strong>Theme 3: Translational and Functional Immunomics</strong>
</p>
<p>Name: Toh Han Chong
<br>Designation: Senior Consultant
<br>Institution: Division of Medical Oncology, National Cancer Centre</p>
<p><strong>Theme 4: Pre-Clinical Disease Modelling and Target Discovery</strong>
</p>
<p>Name: Tam Wai Leong
<br>Designation: Senior Research Scientist
<br>Institution: A*STAR Genome Institute of Singapore</p>
<p>Name: Polly Chen
<br>Designation: Principal Investigator
<br>Institution: Cancer Science Institute</p>
<p><strong>Theme 5: Data Architecture, Data Security and Data Science Applications</strong>
</p>
<p>Name: Liu Nan
<br>Designation: A/Prof
<br>Institution: Centre for Quantitative Medicine, Duke-NUS Medical School</p>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">
<p>Protocol Chair</p>
</td>
<td rowspan="1" colspan="1">
<p>Pierce Chow
<br><a href="mailto:pierce.chow@duke-nus.edu.sg" rel="noopener noreferrer nofollow" target="_blank">pierce.chow@duke-nus.edu.sg</a>
</p>
</td>
</tr>
</tbody>
</table>
<p></p>